{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/eczema-atopic/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"4ff05ba7-7a47-5830-a6d0-a3c723344964","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 7d8ccaf6-9e0a-4c29-be1a-6beef9b182e9 --><h2>How should I diagnose atopic eczema?</h2><!-- end field 7d8ccaf6-9e0a-4c29-be1a-6beef9b182e9 -->","summary":"","htmlStringContent":"<!-- begin item 3847d567-51da-4011-a91c-27fd938fd4cc --><!-- begin field 08c9e134-183b-4f83-9d93-417836c6121f --><ul><li><strong>Take a h</strong><strong>istory. </strong>Ask about:<ul><li><strong>The presence of itching</strong> — the diagnosis is <em>unlikely </em>to be atopic eczema if there is no itch.</li><li><strong>The pattern, time of onset, and natural history of the rash</strong> — atopic eczema usually starts in infancy and is episodic in nature. </li><li><strong>A family or personal history of atopy</strong> — allergic rhinitis and asthma are associated with atopic eczema.</li><li><strong>Any treatments(s) tried and the response to the treatment(s).</strong></li><li><strong>Possible trigger factors (irritant or allergic).</strong> See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/eczema-atopic/diagnosis/identifying-trigger-factors/\">Identifying trigger factors</a> for more information.</li></ul></li><li><strong>Examine the rash.</strong> <ul><li>The distribution and appearance of the rash will be influenced by the person's age and the duration of the rash.<ul><li><strong>In adults, </strong>there is generalized dryness and itching, particularly with exposure to irritants. Eczema on the hands may be the primary manifestation.</li><li><strong>In children and adults with long-standing disease, </strong>eczema is often localized to the flexure of the limbs.</li><li><strong>In infants, </strong>eczema primarily involves the face, the scalp, and the extensor surfaces of the limbs. The nappy area is usually spared.</li><li><strong>Acute eczema (flares) </strong>varies in appearance, from poorly demarcated redness to fluid in the skin (vesicles), scaling, or crusting of the skin.</li><li><strong>Chronic eczema </strong>is characterized by<strong> </strong>thickened (lichenified) skin resulting from repeated scratching.</li></ul></li><li>If eczema is weeping, crusted, or there are pustules, with fever or malaise, secondary bacterial infection should be considered. See <a class=\"topic-reference internal-reference\" href=\"/topics/eczema-atopic/management/infected-eczema/\">Scenario: Infected eczema</a> for management information.</li></ul></li><li><strong>The National Institute for Health and Care Excellence (NICE) states that atopic eczema is likely if the following criteria are fulfilled, </strong>although <a class=\"topic-reference internal-reference\" href=\"/topics/eczema-atopic/diagnosis/differential-diagnosis/\">alternative diagnoses</a> may need to be excluded:<ul><li><strong>An itchy skin condition (or parental report of scratching) <em>plus </em>three or more of the following:</strong><ul><li>Visible flexural eczema involving the skin creases, such as the bends of the elbows or behind the knees (or visible eczema on the cheeks and/or extensor areas in children aged 18 months or younger).</li><li>Personal history of flexural eczema (or eczema on the cheeks and/or extensor areas in children aged 18 months or younger).</li><li>Personal history of dry skin in the last 12 months.</li><li>Personal history of asthma or allergic rhinitis (or history of atopic disease in a first-degree relative of a child aged under 4 years).</li><li>Onset of signs and symptoms before the age of 2 years (this criterion should not be used in children younger than 4 years of age).</li></ul></li><li><strong>Note that </strong>these criteria apply to all ages, social classes, and ethnic groups. However, in children of Asian, black Caribbean, and black African ethnic groups, atopic eczema can affect the extensor surfaces rather than the flexures, and discoid or follicular patterns may be more common.</li></ul></li><li><strong>Investigations</strong> <strong>are not required to establish the diagnosis of atopic eczema. </strong>However, they may be useful in excluding differential diagnoses, especially in people whose symptoms do not respond to treatment.</li><li><strong>If atopic eczema is diagnosed, assess:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/eczema-atopic/management/assessment/#assessing-severity-of-atopic-eczema\">The severity of symptoms</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/eczema-atopic/management/assessment/#assessing-psychological-impact\">The psychological impact on the person</a>.</li></ul></li></ul><!-- end field 08c9e134-183b-4f83-9d93-417836c6121f --><!-- end item 3847d567-51da-4011-a91c-27fd938fd4cc -->","topic":{"id":"63a4e43b-49fe-563e-ac98-e9b0859c592c","topicId":"68307f26-e94a-48b4-9595-fadcb2fdee8a","topicName":"Eczema - atopic","slug":"eczema-atopic","lastRevised":"Last revised in January 2021","chapters":[{"id":"168b58b7-fdd4-50a2-b9ec-27d907398222","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8bb5c02b-0104-5f27-98ba-1b53ded774ba","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"98e1b8e0-503c-57ac-9ef2-caacc212e152","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d176eafc-9dcd-5f10-84a7-1d302a858223","slug":"changes","fullItemName":"Changes"},{"id":"6d4019a1-b2bb-54e9-895a-a2edc7b87429","slug":"update","fullItemName":"Update"}]},{"id":"9c4faee5-cf0b-515b-bc4a-a31602a94782","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"538ef47b-cfe7-5fca-beb8-19aa8e5bf9c1","slug":"goals","fullItemName":"Goals"},{"id":"a0383042-27f4-54a3-a484-e3a5a53f6625","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2c77a3c3-9932-5d7d-91b5-418e832f5312","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8baad0b5-8401-5866-829c-d480e381e783","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a521d8b1-827a-5781-ad45-f3791b4e1bd1","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8cf8749d-acfe-5549-ab78-d5cf32ea5fbf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7eb5aa7-360a-51dc-8e4c-daad28913df0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5a643f13-59c4-52ad-b851-dc4e8a73f354","slug":"definition","fullItemName":"Definition"},{"id":"ebbfabd2-e0e3-5987-aa33-c3fa2ba187da","slug":"causes","fullItemName":"Causes"},{"id":"e7a40326-66ce-59e3-bdcb-86b1b0b611ea","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9944d177-a960-52fd-8b8c-6d34afadddcb","slug":"complications","fullItemName":"Complications"},{"id":"01750b87-b8f0-5ec7-bda0-23ae3f563218","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9692db09-38c6-5f1b-bc48-0e6606729c0c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4ff05ba7-7a47-5830-a6d0-a3c723344964","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b23630ce-69bb-56e8-9fae-e120331f815f","slug":"identifying-trigger-factors","fullItemName":"Identifying trigger factors"},{"id":"9cf9065e-b2c1-545d-a347-325c756ba267","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"084c2672-a546-5c1a-925f-c2b2579ea662","fullItemName":"Management","slug":"management","subChapters":[{"id":"d5478272-79bf-561d-86b2-264a10149cc9","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"0cccd619-b2de-56ab-aa4b-8335f760ada1","slug":"mild-eczema","fullItemName":"Scenario: Mild eczema"},{"id":"fd373e1c-c93c-5467-8984-3ffb57f4db96","slug":"moderate-eczema","fullItemName":"Scenario: Moderate eczema"},{"id":"60c5ed4a-3cf7-5f16-a959-9ebb082384a8","slug":"severe-eczema","fullItemName":"Scenario: Severe eczema"},{"id":"b127c625-6749-5a79-839f-88edee29b634","slug":"infected-eczema","fullItemName":"Scenario: Infected eczema"},{"id":"be3c1aab-3810-578d-a12d-7fa8a3bda3af","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"7a62824e-ab17-5ec8-b4eb-832ae0ea1ed2","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a6a60e24-add6-5b81-96c6-7556a07ce5ef","slug":"stepped-approach-to-treatment","fullItemName":"Stepped approach to treatment"},{"id":"32834cc1-317c-5325-a3c6-54b2bfa53088","slug":"emollients","fullItemName":"Emollients"},{"id":"93edf0ec-6483-5c88-a432-bb01d2b3b606","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"33241bf6-534a-5809-8c00-641507b16a6b","slug":"oral-antihistamines","fullItemName":"Oral antihistamines"},{"id":"f30bf02b-a3bb-581a-bc1f-853575c7f434","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"},{"id":"6432a48a-76f3-534e-a4c1-8ec000fe6d58","slug":"oral-antibiotics","fullItemName":"Oral antibiotics"},{"id":"24b6d226-2567-5496-8557-dbfabde4e855","slug":"topical-antibiotics-antiseptics","fullItemName":"Topical antibiotics and antiseptics"}]},{"id":"a24fe8c8-994b-5b5d-a725-12ab08a2b0e6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"aaad8885-ddf1-52ea-9dbb-520435cbe52b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2a17d479-605d-53c6-aac4-d2dee258e56e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"134abf73-7ae8-51e1-9f52-342c5379bcb0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5fa037f5-1815-5c07-ad67-d491a2c34652","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4a76468f-46d6-51a1-9527-915b5596d2ad","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"15077c82-8b21-52ca-88cb-b5b956cd2ae6","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cc9ef2ce-7217-5486-b5fe-23241bc45da4","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9692db09-38c6-5f1b-bc48-0e6606729c0c","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"bfaf99c1-44ea-5df8-bffa-e695d543a337","slug":"basis-for-recommendation-e3f","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 91935bc3-b88e-4651-969b-562faecf4b7c --><h3>Basis for recommendation</h3><!-- end field 91935bc3-b88e-4651-969b-562faecf4b7c -->","summary":null,"htmlStringContent":"<!-- begin item e3fee3cc-d0bd-4774-9791-becc2aa98c32 --><!-- begin field 0c4ea26a-bb93-40df-8a1b-e613d013b551 --><p>These recommendations are largely based on expert opinion in the National Institute for Health and Care Excellence (NICE) guideline <em>Atopic eczema in under 12s: diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">NICE, 2007a</a>].<em> </em>NICE reviewed this guideline in July 2016 and found no new evidence to warrant a change in recommendations. CKS has extrapolated the recommendations to include the management of older children and adults. </p><p>These recommendations are also in line with those in <em>Management of atopic eczema in primary care </em>published by the Scottish Intercollegiate Guideline Network (SIGN) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">SIGN, 2011</a>], <em>Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis </em>published by the<em> </em>American Academy of Dermatology (AAD) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Eichenfield, 2014a</a>], <em>S2k guideline on diagnosis and treatment of atopic dermatitis - short version </em>(a German guideline<em> </em>supported financially by the<em> </em>German Dermatology Society [DDG]) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Werfel, 2016</a>], and in review articles on atopic eczema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Lyons, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Strathie, 2016</a>].</p><h4>History and examination</h4><ul><li>Expert opinion in guidelines and review articles is that:<ul><li>There are no laboratory or diagnostic tests for atopic eczema. The diagnosis is based on visual assessment and patient history [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">SIGN, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Eichenfield, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Werfel, 2016</a>].</li><li>Itching is the most common feature of atopic eczema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Eichenfield, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Lyons, 2015</a>].</li><li>The major clinical features are an itchy and relapsing eczematous dermatitis in a typical distribution that changes according to stage (acute or chronic) and age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Werfel, 2016</a>].</li></ul></li></ul><h4>Excluding other conditions</h4><ul><li>Guidelines and review articles on atopic eczema highlight the importance of considering differential diagnoses before establishing a diagnosis of atopic eczema, especially if the manifestation or course of the condition is atypical [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Eichenfield, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Strathie, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Werfel, 2016</a>].</li></ul><h4>Investigations not routinely required</h4><ul><li>Expert opinion in an American guideline is that skin biopsies and laboratory testing are usually unnecessary and not helpful in making the diagnosis of atopic eczema. However, they may be beneficial when trying to exclude differential diagnoses, especially in people whose symptoms are not responding to treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/eczema-atopic/references/\">Tollefson, 2014</a>].</li></ul><!-- end field 0c4ea26a-bb93-40df-8a1b-e613d013b551 --><!-- end item e3fee3cc-d0bd-4774-9791-becc2aa98c32 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}